Physiological Factors Affecting Drug Release and Absorption in the Gastrointestinal Tract

Oral Drug Absorption: Prediction and Assessment, Second Edition

Volumn , Issue , 2016, Pages 1-20

  Söderlind, Erik ^a   Dressman, Jennifer B ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136358030     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420077346-2     Document Type: Chapter

References (31)

1. Tanigawara Y. Role of P-glycoprotein in drug disposition. Ther Drug Monit 2000; 22:137-140.
2. Malagelada J-R, Longstreth GF, Summerskill WHJ, et al. Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology 1976; 70:203-210.
3. Christensen J. The motility of the colon. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 2nd ed. New York: Raven Press, 1987:671.
4. Meyer JH. Motility of the stomach and gastroduodenal junction. In: Johnson RL, ed. Physiology of the Gastrointestinal Tract. 2nd ed. New York: Raven Press, 1987:622.
5. Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res 1990; 7:756-761.
6. Mojaverian P. Evaluation of gastrointestinal pH and gastric residence time via the Heidelberg radiotelemetry capsule: pharmaceutical application. Drug Dev Res 1996; 38:73-85.
7. Lindahl A, Ungell A-L, Knutson L, et al. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res 1997; 14:497-502.
8. Press AG, Hauptmann IA, Hauptmann L, et al. Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharmacol Ther 1998; 12:673-678.
9. Efentakis M, Dressman JB. Gastric juice as a dissolution medium: surface tension and pH. Eur J Drug Metab Pharmacokinet 1998; 23(2):97-102.
10. Kalantzi L, Goumas K, Kalioras V, et al. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2005; 23:165-176.
11. Carver PL, Fleisher D, Zhou SY, et al. Meal composition effects on the oral bioavailability of indinavir in HIV-infected patients. Pharm Res 1999; 16:718-724.
12. Hasler WL. Physiology of gastric motility and gastric emptying. In: Yamada T, ed. Textbook of Gastroenterology. 4 ed. Philadelphia: Lippincott Williams and Wilkins, 2003:195-219.
13. Abrahamsson B, Alpsten M, Bake B, et al. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. J Control Release 1998; 52:301-310.
14. Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986; 27:886-892.
15. Abrahamsson B, Alpsten M, Jonsson UE, et al. Gastro-intestinal transit of a multipleunit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon. Int J Pharm 1996; 140:229-235.
16. Davenport HW. Physiology of the Digestive Tract. An Introductory Text. 5th ed. Chicago: Year Book Medical, 1982:181.
17. Moog F. The lining of the small intestine. Sci Am 1981; 245:154-176.
18. Persson EM, Gustafsson A-S, Carlsson AS, et al. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm Res 2005; 22:2141-2151.
19. Nugent SG, Kumar D, Rampton DS, et al. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut 2001; 48:571-577.
20. Woodtli W, Owyang C. Duodenal pH governs interdigestive motility in humans. Am J Physiol 1995; 268:G146-G152.
21. Kalantzi L, Persson E, Polentarutti B, et al. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm Res 2006; 23:1373-1381.
22. Persson EM, Nilsson RG, Hansson GI, et al. A clinical single-pass perfusion investigation of the dynamic in vivo secretory response to a dietary meal in human proximal small intestine. Pharm Res 2006; 23:742-751.
23. McNamara DP, Whitney KM, Goss SL. Use of physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs. Pharm Res 2003; 20:1641-1646.
24. Schiller C, Fröhlich C-P, Giessmann T, et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2005; 22:971-979.
25. Gotch F, Nadell J, Edelman IS. Gastrointestinal water and electrolytes. IV. The equilibration of deuterium oxide (D2O) in gastrointestinal contents and the proportion of total body water (T.B.W.) in the gastrointestinal tract. J Clin Invest 1957; 36:289-296.
26. Weitschies W, Kosch O, Mönnikes H, et al. Magnetic marker monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv Drug Deliv Rev 2005; 57:1210-1222.
27. Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28:1221-1227.
28. Diakidou A, Vertzoni M, Goumas K, et al. Characterization of the contents of the human ascending colon under conditions simulating bioavailability-bioequivalence studies. Abstract of Papers, American Association of Pharmaceutical Scientists Annual Meeting and Exposition, Atlanta, GA, 2008, November 16-20.
29. Diakidou A, Vertzoni M, Goumas K, et al. Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults. Pharm Res 2009; 26:2141-2151.
30. Badley AD, Camilleri M, O’Connor MK. Noninvasive measurement of human ascending colon volume. Nucl Med Commun 1993; 14:485-489.
31. Wilson CG, Kelly K. Gastrointestinal transit and drug absorption. In: Dressman J, Krämer J, eds. Pharmaceutical Dissolution Testing. Boca Raton: Taylor and Francis Group, 2005:97-125.